Functional opioid receptor sites in human placentas

Area of Science:

• Reproductive biology
• Endocrinology
• Pharmacology

Background:

• Opioid peptides and their receptors are present in various tissues, influencing diverse physiological processes.
• The role of opioid peptides and their specific receptor subtypes in placental function remains incompletely understood.

Purpose of the Study:

• To characterize opioid peptide receptor sites in human midterm and term placental plasma membranes and cells.
• To investigate the functional role of these receptors in regulating placental lactogen secretion.

Main Methods:

• Radioligand binding assays using [3H]ethylketo-cyclazocine (EKC) to identify and quantify kappa-type opioid receptors.
• Scatchard analysis to determine binding affinity (Ka) and receptor density.
• Incubation of term placental cells with opioid peptides to assess effects on placental lactogen production.

Main Results:

• High-affinity, kappa-type opioid peptide receptor binding was identified in both midterm and term placental plasma membranes and cells.
• Receptor density in placental plasma membranes significantly increased from midterm to term pregnancy.
• Kappa-opioid receptor activation in term placental cells led to a significant increase in placental lactogen production, blocked by naloxone.

Conclusions:

• Human placenta expresses functional kappa-type opioid peptide receptors.
• Opioid peptides, acting via kappa receptors, play a role in regulating placental lactogen secretion.
• These findings contribute to understanding neuroendocrine regulation within the placenta.